Sun Pharma to acquire DUSA Pharmaceuticals
DUSA’s Levulan combination therapy is for treatment of non-hyperkeratotic actinic keratoses
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.